Search Results

There are 10651 results for: content related to: Use of Naltrexone in the Treatment of Alcoholism Nationally in the Department of Veterans Affairs

  1. You have free access to this content
    Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review

    CNS Neuroscience & Therapeutics

    Volume 17, Issue 6, December 2011, Pages: 629–636, Philipp P. Lobmaier, Nikolaj Kunøe, Michael Gossop and Helge Waal

    Version of Record online : 23 SEP 2010, DOI: 10.1111/j.1755-5949.2010.00194.x

  2. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research

    Addiction

    Volume 108, Issue 2, February 2013, Pages: 233–247, Hendrée E. Jones, Margaret S. Chisolm, Lauren M. Jansson and Mishka Terplan

    Version of Record online : 4 APR 2012, DOI: 10.1111/j.1360-0443.2012.03811.x

  3. A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence

    Drug and Alcohol Review

    Volume 33, Issue 2, March 2014, Pages: 115–128, Sarah Larney, Linda Gowing, Richard P. Mattick, Michael Farrell, Wayne Hall and Louisa Degenhardt

    Version of Record online : 3 DEC 2013, DOI: 10.1111/dar.12095

  4. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

    Addiction

    Volume 108, Issue 2, February 2013, Pages: 275–293, Natalya C. Maisel, Janet C. Blodgett, Paula L. Wilbourne, Keith Humphreys and John W. Finney

    Version of Record online : 17 OCT 2012, DOI: 10.1111/j.1360-0443.2012.04054.x

  5. You have free access to this content
    Improving clinical outcomes for naltrexone as a management of problem alcohol use

    British Journal of Clinical Pharmacology

    Volume 76, Issue 5, November 2013, Pages: 632–641, Gary K. Hulse

    Version of Record online : 21 OCT 2013, DOI: 10.1111/j.1365-2125.2012.04452.x

  6. Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing

    Clinical Pharmacology & Therapeutics

    Volume 20, Issue 3, September 1976, Pages: 315–328, Karl Verebey, Jan Volavka, Salvatore J. Mule and R. B. Resnick

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1976203315

  7. Pharmacokinetics of Long-Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 45, Issue 11, November 2005, Pages: 1259–1267, Dr Ryan Z. Turncliff, Dr Joi L. Dunbar, Dr Qunming Dong, Dr Bernard L. Silverman, Dr Elliot W. Ehrich, Dr Stacy C. Dilzer and Dr Kenneth C. Lasseter

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270005280199

  8. Naltrexone and Dysphoria: Fact or Myth?

    The American Journal on Addictions

    Volume 11, Issue 2, Spring 2002, Pages: 151–160, Karen Miotto, Michael McCann, Janice Basch, Richard Rawson and Walter Ling

    Version of Record online : 18 FEB 2010, DOI: 10.1080/10550490290087929

  9. Naltrexone, opiate addiction, and endorphins

    Medicinal Research Reviews

    Volume 2, Issue 3, July/September 1982, Pages: 211–246, Mark S. Gold, Charles A. Dackis, A. L. C. Pottash, Harvey H. Sternbach, William J. Annitto, David Martin and Marcy Pasternak Dackis

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610020302

  10. Naltrexone maintenance for heroin dependence: uptake, attrition and retention

    Drug and Alcohol Review

    Volume 23, Issue 3, September 2004, Pages: 299–309, Dr THAMIZAN K. TUCKER, ALISON J. RITTER, CLAIRE MAHER and HENRY JACKSON

    Version of Record online : 29 MAY 2009, DOI: 10.1080/09595230412331289464

  11. You have free access to this content
    Injectable and implantable sustained release naltrexone in the treatment of opioid addiction

    British Journal of Clinical Pharmacology

    Volume 77, Issue 2, February 2014, Pages: 264–271, Nikolaj Kunøe, Philipp Lobmaier, Hanh Ngo and Gary Hulse

    Version of Record online : 22 JAN 2014, DOI: 10.1111/bcp.12011

  12. You have free access to this content
    Kinetics and inhibition of the formation of 6β-naltrexol from naltrexone in human liver cytosol

    British Journal of Clinical Pharmacology

    Volume 50, Issue 5, November 2000, Pages: 465–471, Susan J. Porter, Andrew A. Somogyi and Jason M. White

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.2000.00281.x

  13. Naltrexone in the treatment of heroin dependence: a literature review

    Drug and Alcohol Review

    Volume 19, Issue 1, March 2000, Pages: 73–82, THAMIZAN K TUCKER and ALISON J. RITTER

    Version of Record online : 29 MAY 2009, DOI: 10.1080/09595230096174

  14. Naltrexone Effects on Ethanol Drinking Acquisition and on Established Ethanol Consumption in C57BL/6J Mice

    Alcoholism: Clinical and Experimental Research

    Volume 21, Issue 4, June 1997, Pages: 691–702, Tamara J. Phillips, Charlotte D. Wenger and Janet D. Dorow

    Version of Record online : 30 MAY 2006, DOI: 10.1111/j.1530-0277.1997.tb03824.x

  15. ‘Miracle cure’ or ‘liquid handcuffs’: Reporting on naltrexone and methadone in the Australian print media

    Drug and Alcohol Review

    Volume 33, Issue 5, September 2014, Pages: 506–514, Francis Matthew-Simmons and Alison Ritter

    Version of Record online : 18 MAR 2014, DOI: 10.1111/dar.12134

  16. Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence

    Addiction

    Volume 109, Issue 8, August 2014, Pages: 1274–1284, James C. Garbutt, Amy M. Greenblatt, Suzanne L. West, Laura C. Morgan, Alexei Kampov-Polevoy, Harmon S. Jordan and Georgiy V. Bobashev

    Version of Record online : 22 MAY 2014, DOI: 10.1111/add.12557

  17. Social Network Moderators of Naltrexone and Behavioral Treatment Effects on Heavy Drinking in the COMBINE Study

    Alcoholism: Clinical and Experimental Research

    Volume 39, Issue 1, January 2015, Pages: 93–100, Matthew J. Worley, Katie Witkiewitz, Sandra A. Brown, Daniel R. Kivlahan and Richard Longabaugh

    Version of Record online : 26 JAN 2015, DOI: 10.1111/acer.12605

  18. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis

    Addiction

    Volume 110, Issue 6, June 2015, Pages: 920–930, Kim Donoghue, Catherine Elzerbi, Rob Saunders, Craig Whittington, Stephen Pilling and Colin Drummond

    Version of Record online : 17 MAR 2015, DOI: 10.1111/add.12875

  19. You have free access to this content
    Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels

    Arthritis & Rheumatism

    Volume 65, Issue 2, February 2013, Pages: 529–538, Jarred Younger, Noorulain Noor, Rebecca McCue and Sean Mackey

    Version of Record online : 28 JAN 2013, DOI: 10.1002/art.37734

  20. Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis

    Addiction Biology

    Volume 17, Issue 3, May 2012, Pages: 505–512, Antonio-Javier Chamorro, Miguel Marcos, José-Antonio Mirón-Canelo, Isabel Pastor, Rogelio González-Sarmiento and Francisco-Javier Laso

    Version of Record online : 19 APR 2012, DOI: 10.1111/j.1369-1600.2012.00442.x